Is Canopy Growth Stock a Buy in December 2022?

Canopy Growth stock climbed 80% before falling back once more. So should you jump on an opportunity, or be fearful of another drop?

| More on:
Cannabis grows at a commercial farm.

Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Canopy Growth (TSX:WEED) has received some attention over the last few months, with a few headlines bringing the share price higher. In fact, shares soared by 80% between October and November, before falling back.

Even after the climb, shares of Canopy Growth stock are still down by about 70% year to date. That’s even more when you consider all-time highs. Yet with all this renewed attention to the industry, is Canopy Growth stock a buy in December 2022?

What’s been happening

In October, headlines started exploding when President Joe Biden stated he would pardon those who received a criminal charge for simple marijuana possession, and urged states to do the same. This was a major step towards what the administration hoped to achieve on election: marijuana decriminalization.

This positive sign looked like enough for Canopy Growth stock to move forward with its plan for United States domination. The company announced it would go through with its 100% ownership of Acreage, expanding its U.S. operations significantly.

This caused the share spike we saw back in October. Yet, then shares dropped back once again. So what happened?

Created with Highcharts 11.4.3Canopy Growth PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.ca

Oh, right, earnings

While it was great to see the company move forward with the Acreage plan, it still didn’t solve the earnings problem. Canopy Growth stock has been chipping away at its losses, which are significant. It has closed operations, and focused on its non-marijuana business ventures, such as BioSteel, to move towards profitability.

This has been the main focus of the last few years, but it’s still a work in progress. During the most recent earnings report, Canopy Growth stock announced revenue growth of 7% year over year, with a 299% net revenue increase from BioSteel. The company also divested some Canadian retail operations, to bring in $70 to $100 million in savings. The loss now stands at $232 million.

What investors should think

Canopy Growth stock has been improving its debt. The new Acreage operations will also certainly help bring in cash flow. Further, more states than ever plan to allow the recreational use of cannabis. However, there is still more work to be done.

As we head into a potential recession, it could very well be that Canopy Growth stock gets worse before it gets better. If you’re willing to wait a while (and I do mean a while), then by all means get into the cannabis industry. It’s set to continue climbing, and Canopy Growth stock could honestly end up being the biggest cannabis producer in the world over the next decade.

However, that doesn’t mean there would not be risks along the way. And I’ll be honest, I do not think you should sink a bunch of cash into this stock. It’s far too risky, and should an emergency come up where you need the dough, you could be out of luck.

So, bottom line, Canopy Growth stock is a great opportunity if you’re looking for a small stake you could drip feed into. However, if you think it’s about to get you rich in the months to come, I’d certainly think again.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »